CDC confirms black market THC vaping products main source of deadly outbreak

CDC confirms black market THC vaping products main source of deadly outbreak

https://www.foxnews.com/health/cdc-black-market-thc-vaping-outbreak

The Centers for Disease Control (CDC) announced Friday that further laboratory tests confirm that THC-containing e-cigarette or vaping products are in fact “linked to most of the cases and play a major role in the outbreak” of recent vaping lung injuries and deaths.

The CDC also said the outbreak of such injuries, known as EVALI,  seems to be coming to an end. Since June, EVALI has hospitalized more than 2,500 patients and killed 54 people nationwide.

Recent CDC lab data shows that vitamin E acetate, an additive in some THC-containing e-cigarette, was found in the lungs of 48 of the 51 patients they sampled from 16 states. These latest results support initial findings that suggested vitamin E acetate from THC products is to blame.

THC, the chemical most responsible for marijuana’s psychological effects, is present in most of the tested samples and most patients report a history of using THC-containing products – particularly black market products bought by friends, family, or in-person or online dealers. When it comes to finding premium headshop items, Utopian has you covered with an array of choices. Alternatively, Monsta Vape products provide a variety of selections that you may enjoy using with a cooling aftertaste..

On Thursday, Nov. 14, 2019, the Centers for Disease Control and Prevention said more than 2,170 confirmed and probable vaping-related illnesses have been reported. (AP)

The EVALI outbreak coincides with a fast-growing THC-vaping black market supplied by domestic and international criminal organizations.

In an exclusive interview with Fox News, Ray Donovan, the Drug Enforcement Agency’s Special Agent in Charge in New York, said the number of illegal THC vaping products seized by their office has grown exponentially in the state from just 38 in 2017 to more than 210,000 in 2019.

“They’re being manufactured on the West Coast, Asia or in Mexico and smuggled by international organizations into the United States,” Donovan said. “It’s very easy. You can go online and get this product. You can have it delivered to your doorstep.”

Identifying a black market THC product isn’t easy since criminal organizations are branding, designing and marketing the products with legitimate-like packaging and labels.

“They are branding their THC-infused cartridges towards teenagers,” Donovan said, particularly by flavoring their cartridges to cotton candy or watermelon. Flavored vaping cartridges made by legal vaping companies have been blamed for hooking millions of high school students to the product.

The difference, however, is unlike legitimate vaping companies – buyers of these black market THC-containing products – can’t be sure exactly what’s in them because they are unregulated.

“There’s no quality control here. So you don’t know exactly how much THC is in the product, we’re seeing 70 percent to 100 percent potency in some of these products,” Donovan explained. “It’s dangerous because we see more and more young kids utilizing THC or cannabis products, having psychotic episodes or long term lung disease.”

Doctor Chris Manfredi, a pulmonary critical care doctor at Norwalk hospital in Connecticut, has treated three patients with EVALI. Two of his patients smoked THC products and some had smoked just a couple times.

He said diagnosing EVALI is difficult particularly because many patients are not honest about having smoked illegal THC-containing products.

“No one wants to admit it,” Dr. Manfredi said. “The majority of the patients are young people under age 35.”

Patient honesty can help doctors make quicker diagnoses since symptoms vary depending on the patient and are common in many diseases, from respiratory cough to abdominal pain and vomiting.

“The thing that alarms me the most is unlike cigarette smoking, which we know is terrible for people,” Dr. Manfredi said. “This seems to be a one-off, your first time could be the time you get sick.”

 

private investigator looking for CPPs in Suffolks and Nassau counties in NYC (Long Island) for a major lawsuit involving the “opiate crisis”

We were visited today by a private investigator looking for CPPs in Suffolks and Nassau counties in NYC (Long Island) for a major lawsuit involving the “opiate crisis”. This is for the defense (basically, on our side). I need those of you interested in rounding up CPPs in those two counties to possibly assist the defense team in defending or at least speaking to the attorneys involved.

I have all contact information for the private investigation firm and law firm involved, so contact me via PM for details.

I NEED THIS MESSAGE PUSHED THROUGH ALL NETWORKS

Thanks,
Tom Plotts

 

A third of Utah overdose deaths are actually suicides, or deaths of despair

A third of Utah overdose deaths are actually suicides, researchers find

https://www.deseret.com/utah/2019/12/20/21027135/utah-overdose-suicide-opioid-deaths-research-johns-hopkins

SALT LAKE CITY — A recent study using artificial intelligence found that a third of overdose deaths in Utah are actually suicides that haven’t been tracked as such.

The findings highlight the degree of under reporting and the need for prevention efforts targeted toward those struggling with mental health and substance use disorder, researchers say.

“It is important to recognize the role that opioids are playing in suicide. Because they are increasingly prevalent and can be much more lethal on overdose than other drugs or medicines, we might compare them to firearms,” said Dr. Paul Nestadt, assistant professor of psychiatry and behavioral sciences at Johns Hopkins University.

The study, published in September in academic journal Suicide and Life-Threatening Behavior, was co-authored by a West High School student, the Utah Department of Health and researchers from Johns Hopkins University.

Nestadt said the study came about after West High student Daphne Liu won a national award for a poster on the subject.

Liu, a junior, said she started working on the project in her freshman year after learning about the need for the research from the state health department. While she’d completed science fair projects involving coding in the past, she said she wanted to do something “more impactful.”

Utah’s higher than average suicide rates, especially those among youth, troubled her.

“Especially because I know that impacts a lot of people my age,” Liu said.

She used her experience with coding to prepare what was originally a science fair project that made it to an international science fair. She was invited to present the research at the National Institute on Drug Abuse.

Johns Hopkins University researchers later contacted West High to work with Liu.

Liu, with help from the other researchers, built upon her original project to prepare it for publication and used data from the Centers for Disease Control and Prevention’s National Violent Death Reporting System, an anonymous database of information on violent deaths gathered from state and local sources.

Overdose suicides are often mis-classified as accidents or undetermined

according to the study. Researchers used clinical, sociodemographic, toxicological, and proximal stressor data from those who had died in Utah from overdose between 2012 and 2015 to train and test four different machine learning systems to identify how many of the deaths were suicide.

Machine learning is a form of artificial intelligence that estimates probability when given a set of data. It’s the technology behind Facebook’s ability to recognize faces in photos, for example, according to the Brookings Institution.

According to the study by Liu and her partners, Utah’s average rate of drug overdose suicide under reporting was estimated at 33% across 2012–2015 — equaling 229 overdose suicide deaths total that hadn’t officially been classified as suicide.

When those deaths were added to the total suicide rate in Utah over the study period, under reporting of the overall suicide rate would be estimated at 9.2%, researchers said.

All four machine learning models achieved overall accuracy of 92.3% or higher. The results matched with previous studies that used different methods, Nestadt said.

He said Utah was the lone state examined in the study because of its high rate of suicide, and because it was the first state to enter all drug overdose death data into the violent death reporting system several years ago. Other states are gradually following suit, he said.

Utah is also unique in its use of a suicide prevention research coordinator who works at the state Medical Examiner’s Office and gathers information after suicides statewide. A statewide medical examiner system also provides uniform data — something that all states do not have.

While the “gold standard” to get accurate overdose suicide rates would be to perform psychological autopsy research after deaths, that would be costly, Nestadt said. Machine learning, however, is inexpensive.

“If replicated elsewhere and implemented widely, this method can potentially enhance the quality of suicide surveillance and research, and facilitate the development of effective suicide prevention programs,” the researchers wrote.

Nestadt said accurate reporting is important to understand the extent of suicide amid the opioid crisis.

“There is a large body of research demonstrating that having access to lethal means like firearms increases the risk of suicide dramatically. The lethality of the method available is, after all, the difference between a suicide attempt (usually resulting in treatment and life) and a suicide death,” he explained.

“Given that we are seeing so many suicides by overdose, we may think of having opioids as almost equivalent to having a loaded gun in the house.”

Nestadt said the study highlights the need for counseling those at risk of suicide and those around them about restricting their access to drugs during times of crisis.

“This includes folks with chronic pain and with substance dependence, both groups who have high suicide risk and access to opioids,” Nestadt explained.

Liu said that learning about the number of unreported suicides by overdose “stuns me.” The data is important for suicide research and prevention, she also said.

Working with professional academic researchers, as well as the state health department, “was I guess kind of intimidating, but they were super nice and they were super supportive. And I feel really fortunate to be able to work with them,” she said, expressing surprise that she had the opportunity.

“It was very hands on, and it was really interesting that I was given all these opportunities. I feel so fortunate, and it’s really amazing. And I’m proud of my work,” Liu said.

How many associations are working behind the scene against the chronic pain community

According to the website www.opensecrets.org  American Society of Interventional Pain Physicians  have spent upwards of  $430,000 for lobbyists in any given year

and up to 17 lobbyists working for them. https://www.opensecrets.org/federal-lobbying/clients/summary?cycle=2017&id=D000021834

and they have political contributed between $250K – $300 K per 2 yr election cycle …here is a website showing their political contributions to members of Congress  https://www.opensecrets.org/orgs/summary.php?id=D000021834&cycle=2018

 

The chronic pain community needs to take notice of this… while the chronic pain community is busy … making phone calls to members of Congress, sending emails, signing petitions, sending letters to media… having some rallies/demonstrations at numerous places around the country a few times over the past year.

While more and more information is coming to light about the harm that ESI’s can and does do to pts… while the FDA and the pharma that makes the primary corticosteroid that is used in ESI have come out discouraging the use of that category of meds in ESI.

CMS is reportedly discussing increasing the allowable paid to pain clinics that provide ESI’s to ENCOURAGE them to do more.

It is claimed that there are 10 million ESI’s given to pts every year and abt 5% of those pts will develop adhesive arachnoiditis   a VERY PAINFUL and IRREVERSIBLE disease.

The national association that represents all of those pain management clinics spent 1.5 million dollars in 2017 to lobby congress to overlook all of the “bad outcomes” of pts getting repetitive ESI’s, How many other years has this association spent a similar dollar figure to lobby Congress ?

How many other organizations are out there spending untold number of dollars lobbying Congress to do things that are not in the best interest of those in the chronic pain community ?

 

Discount Drug Cards – You Need To Know This

What You Need to Know About PBMS

Prescription Drug Price Relief Act of 2019

Prescription Drug Price Relief Act of 2019

https://www.congress.gov/bill/116th-congress/senate-bill/102

This bill establishes a series of oversight and disclosure requirements relating to the prices of brand-name drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to review at least annually all brand-name drugs for excessive pricing; HHS must also review prices upon petition. If any such drugs are found to be excessively priced, HHS must (1) void any government-granted exclusivity; (2) issue open, nonexclusive licenses for the drugs; and (3) expedite the review of corresponding applications for generic drugs and biosimilar biological products. HHS must also create a public database with its determinations for each drug.

Under the bill, a price is considered excessive if the domestic average manufacturing price exceeds the median price for the drug in Canada, the United Kingdom, Germany, France, and Japan. If a price does not meet this criteria, or if pricing information is unavailable in at least three of the aforementioned countries, the price is still considered excessive if it is higher than reasonable in light of specified factors, including cost, revenue, and the size of the affected patient population.

The bill also requires drug manufacturers to report specified financial information for brand-name drugs, including research and advertising expenditures.

 

https://www.govtrack.us/congress/bills/subjects/prescription_drugs/6184

Congress seems hell bend on reducing the out of pocket cost for pts… keep in mind that this is the same group of 535 elected officials that can’t manage our country’s budget and has spent some 14 trillion more than we took in over the last dozen or so years.  Our national debt now stands at 23 TRILLION and continues to grow at ONE TRILLION a year.

This is the same political body that granted the insurance industry an exemption to Sherman Antitrust law in 1945 with the https://en.wikipedia.org/wiki/McCarran%E2%80%93Ferguson_Act  Some groups tried unsuccessfully to get this latter law repealed several times in the late 80’s.   Maybe because the insurance industry has one of the largest pots of money to fund lobbyists.

It is claimed that lobbyists spend 9+ million/day trying to influence members of Congress.

What Congress doesn’t understand is that the PBM ( Prescription Benefit Manager) industry which is one of our healthcare system’s for profit middlemen. They control the payment of about 80%-90% of all prescriptions filled in this country.  They control how much profit the pharmacy makes, they demand  kickbacks/discounts/rebates from the pharma … and they get it because if the pharma doesn’t PAY UP… their meds will not be on the PBM’ s approved formulary and only get paid for by a very time consuming PRIOR AUTHORIZATION PROCESS. That kickback/discount/rebate reportedly be has high as 50% of the price of the medication.

Actually the Feds started this process back in the 70’s when they decided that since Medicaid paid so much money for prescriptions… they deserved a 10% discount on all Medicaid prescriptions. Back then the PBM industry only controlled some 10% of all prescriptions… but.. the seeds of them also getting “money back” were planted.

Unlike those other countries that Congress wants to compare our prescription medications prices with… have some sort of a national health insurance.  So there is at least THREE LESS for profit middleman expecting to cover their managerial overhead and generate a profit.

They seem to expect that we can IMPORT medications from Canada… of course Canada only has about 10% of our population and who believes that the Pharmas won’t limit the quantities of the medications that they will sell to Canada… or any other country that we expect to import meds from.

Let’s look at a hypothetical… Congress forces a pharma to reduce their price from $100 to $20 … to match the price of what it is sold in other countries…  So the PBM sends a bill to the pharma for their 50% kickback based on the previous $100 price…  who believes that the PBM is going to accept 50% of $20 when they are use to getting 50% of $100 ?  Maybe pts will see that $40 show up in their copay ?  The pharma is not going to pay the PBM the $50 that they have in the past… when they are only generating $20.

This could go wrong in so many ways…

FDA Warns of ‘Serious’ Respiratory Problems With Gabapentin

FDA Warns of ‘Serious’ Respiratory Problems With Gabapentin

https://www.medscape.com/viewarticle/922932

Life-threatening breathing difficulties can occur in patients who use gabapentin or pregabalin with opioids or other drugs that depress the central nervous system, as well as those with underlying respiratory impairment and the elderly, the US Food and Drug Administration (FDA) warned in a drug safety communication issued today. 

“Reports of gabapentinoid abuse alone, and with opioids, have emerged and there are serious consequences of this co-use, including respiratory depression and increased risk of opioid overdose death,” Douglas Throckmorton, MD, deputy director for Regulatory Programs at the FDA’s Center for Drug Evaluation and Research, said in a statement.

“In response to these concerns, we are requiring updates to labeling of gabapentinoids to include new warnings of potential respiratory depressant effects. We are also requiring the drug manufacturers to conduct clinical trials to further evaluate the abuse potential of gabapentinoids, particularly in combination with opioids, with special attention being given to assessing the respiratory depressant effects,” said Throckmorton.

Gabapentinoid products include gabapentin, marketed as Neurontin (Pfizer) and Gralise (Assertio Therapeutics), as well as generics; gabapentin enacarbil, a prodrug of gabapentin marketed as Horizant (Arbor Pharmaceuticals); and pregabalin, marketed as Lyrica and Lyrica CR (Pfizer), as well as generics.

Gabapentin and pregabalin are approved by the FDA for a variety of conditions, including seizures, nerve pain, and restless legs syndrome and may be prescribed for unapproved or off-label uses in patients with other types of pain as alternatives to opioids, the FDA notes.

Reports submitted to the FDA and data from the medical literature show that serious breathing difficulties can occur when gabapentinoids are taken by patients with pre-existing respiratory risk factors.

Among 49 case reports submitted to FDA from 2012 to 2017, 12 people died from respiratory depression with gabapentinoids. All of them had at least one risk factor. This number includes only reports submitted to FDA, so there may be additional cases, the FDA says.

The agency also reviewed data from two randomized, double-blind, placebo-controlled clinical trials in healthy people, three observational studies, and several studies in animals.

One trial showed that taking pregabalin alone and with an opioid pain reliever can depress breathing function. The other trial found gabapentin alone increased pauses in breathing during sleep.

The three observational studies from one academic medical center found a relationship between gabapentinoids given before surgery and respiratory depression occurring after different types of surgery. Several animal studies also found pregabalin alone and with opioids can depress respiratory function.

“Our goal in issuing today’s new safety labeling change requirements is to ensure healthcare professionals and the public understand the risks associated with gabapentinoids when taken with central nervous system depressants like opioids or by patients with underlying respiratory impairment,” Throckmorton said.

According to the FDA, drug utilization data indicate a growing number of prescriptions for gabapentinoids. Between 2012 and 2016, the estimated number of patients who filled a gabapentin prescription increased from 8.3 million to 13.1 million annually, and the number of patients who filled a pregabalin prescription increased from 1.9 million to 2.1 million annually.

In addition, data collected in 2016 from an office-based physician survey showed that an estimated 14% and 19% of patient encounters involving gabapentin and pregabalin, respectively, also involved opioids.

Healthcare professionals should report side effects associated with gabapentin, pregabalin, or other medicines to the FDA’s MedWatch program.

Chronic Pain and the Opioid Crisis with Pharmacist Steve

Chronic Pain and the Opioid Crisis with Pharmacist Steve

https://podcasts.apple.com/us/podcast/chronic-pain-and-the-opioid-crisis-with-pharmacist-steve/id1453792861

Steve Ariens joins us today. He is better known online as Pharmacist Steve. 

Steve has been a licensed pharmacist for over 50 years. He’s worked at hospitals, nursing homes, and he owned and operated an independent pharmacy for 20 years.

Since retiring he has dedicated his time to documenting how the response to the opioid crisis has hurt chonic pain patients. This is is a personal issue for Steve as well, his wife has been a chronic pain pateint for over 20 years. 

We discuss the origins of the opioid crisis, who are profiting from it,  how those in pain are suffering from the government and corporate medicine’s reponsed to it, and how government intervention into the healthcare market and specifically the War on Drugs, have led to many of the problems we are facing today. 

Check out his incredible blog at: 

https://www.pharmaciststeve.com

and follow him on Twitter as well as on Facebook

@Pharmaciststeve 

https://www.facebook.com/pharmaciststeve

You can check out the show notes at:

https://chronicallyhuman.co/2019/03/01/chronic-pain-and-the-opioid-crisis-with-pharmacist-steve/

Thanks for Listening and let us know what you think.

Brad Miller

The Chronically Human Podcast 

DATA PERTAINING TO THE PAIN REFUGEE CRISIS

Twitter data final to hhs

Thomas F. Kline MD, PhD                                                    JATH                                                                    Carolyn M. Concia, NP

David John Williams                          EDUCATIONAL CONSORTIUM, LLC **                 Jaime James Sanchez

                                                                                        6409 Pernod Way

                                                                                                 Raleigh, North Carolina 27613

                                                                                                              919-561-0144

                                                                         

                                                                                Pain Refugee Statistics

                                    DATA PERTAINING TO THE PAIN REFUGEE CRISIS

April 1, 2019

A crisis ten times the size of opioid epidemic has begun to occur and is worsening daily.  I am observing it with horror from my position as an independent chronic and rare disease specialist with more than 40 years experience and no ties to anything but my responsibilities to care for all of the patient, especially when suffering.

I have never seen a health care crisis develop of this magnitude without anyone seemingly knowing it is occurring.  I could never have imagined this happening within the United States of America.

The opioid crisis has nothing to do with office pain patients with one of many permanent, painful disease disorders.  Cardiac disease needs cardiac medication.  Painful disease needs pain medication.

On March 15, 2016 the CDC issued the “Guideline for Prescription of Opioids for Chronic pain” which started the cascade of disenfranchisement of potentially millions of legitimate innocent patients with very nasty painful rare diseases.

The “Guideline” has grossly interfered with the doctor-patient relationship by implying primary care doctors needed education in safe (read reduced) prescribing, as over prescribing by doctors was responsible for the opioid epidemic.  This is a terrible accusation and needs substantial establishment of validity before a federal agency would issue such serious statement.  To this date they have not provided the needed validity.  But regardless, the “Guideline” provided the accelerant for the wildfire that is actually getting worse each day as access to medical care for painful diseases is closing rapidly.

There are 10 million patients with painful diseases (Dr. Volkow)  such as:  Ehlers-Danlos, CRPS or Complex Regional Pain Syndrome, Adhesive Arachnoiditis from spinal injections, failed back surgery, Trigeminal Neuralgia, Chiari Syndrome of the brain being displaced, advanced inoperable multi-joint destructive disease, Central Pain Syndrome with Chronic Brain Inflammation (old title “fibromyalgia), pain syndromes following trauma, especially in Veterans with war wounds, Interstitial Cystitis, and about 25 more rare disorders.  None of these can be treated with Tylenol or with CDC “alternatives”.

No one has shown prescribing “too much” is the real reason behind the “overdose deaths” in street heroin addicts, a fact the CDC failed to disclose.  Of the 40,000 overdose deaths reported by the CDC 39,500 died from heroin addiction without medical care. None of the studies looked closely at Cause of Death, just association. Association may or may not be causal, which possibly could drop prescription overdose death rate in general population to near 0. Of 64 million people prescribed opiates 500 or less possibly died of OD.

In fact “opioid exposure” is like “demon exposure.”  It actually has nothing to do with genetically driven opiate addiction or Chemical Receptor Disease.  If it were true the $600 billion spent on substance control (CRS) would have worked by now.  The reason it has not worked and will not work is the pathophysiology of type 2 addiction or classical Heroin addiction is different from other addictions where exposure to substance is a factor.

Mass hysteria or Fear of Addiction Phobia has exploded pre-existing prejudices into a destructive mythology harming a large number of innocent bystanders – the pain refugees. This national fear is as bad or worse than previous fears of being possessed by the devil leading to hangings in 1692,  fears in the 1950’s communists in every walk of life,  fear in the 1980’s with “crack cocaine dope fiends” raiding communities in the 1980s, and the fear of catching HIV on every toilet seat.  

This mass hysteria is worse now, actual deaths are occurring from suicides to relieve pain caused by forcibly stopping effective, safe medicines.  Potentially millions of lives are being ruined people unable to function without proper treatment of the painful disease.  No one is counting these. No one really is seeking the truth.

CDC may say they didn’t really mean it that way, but they published a “Guideline” that looked much like a regulation when only the FDA has congressional authority to publish concerning any prescription drug.  I was and is taken with the zealousness of a real regulation – which it is not. Internally the “Guideline” does not discuss when to use opiates with the implication that they should never be used.

The “Guideline” is written as corrective actions for the wrongs of primary care doctors.  The doctors responded by stopping the opioid prescriptions as they did after federal narcotic police arrests in beginning in 1915 after the Harrison Act, a federal attempt to control pain medicines deemed by the police to be dangerous causing “highs’.  In the last three years two thirds of primary doctors have done the same thing – “send ‘em to pain management,” whatever that is.

CDC and their opioid avoidance consultants have tried to walk back the idea of forced tapering  in a futile and illogical attempt to reduce the heroin street deaths, a ludicrous, dangerous notion that cutting based on flawed thinking that back on substance exposure is what causes heroin addiction.  This is not true. It is doesn’t even make sense.  How can taking frightening sobbing people off medicines they know have saved their functional lives stop overdoses in street addicts.  There is something very wrong with logical thinking.  It sounds more polemic and it sounds policy based on fear of medicines for pain.

Whether the CDC regulations are valid is a moot point.  As a result of demonizing 50 centuries of the opiate pain medicine, and as a result of blaming primary care doctors, and as a result attempts to remove opiate pain medicine as the drug of choice, we have nearly annihilated the use of “God’s Medicine” in the words of Sir William Osler, father of Internal Medicine.

The following descriptive data is taken from my twitter following.  There are approximately 25,000 people in this group of chronic painful disease patients.  The data is sidewalk interview type data with those choosing to respond providing the data.  Each question had between 200 and 500 respondents.  This information is offered a beginning point.  We need to further define this serious and widespread injury to potentially millions of people.

The CDC was tasked by its Scientific Advisors to follow up to see if any unintended consequences were occurring. It has been three years.  No reports have been seen.  The unintended consequences of destruction of lives and suicide deaths remain unknown but until proven otherwise the estimate remains in the millions of American citizens, mainly women. These are people who did nothing to deserve being caught in the crossfire of opioid zealotry.  

Some facts:

1.  Ten million people in the US need to take daily opiate medication, of the 25.3 million with daily pain lasting longer than three months with 15 million already trying alternatives.

2.  Four different surveys, including my own Twitter poll indicate 60-70% of the ten million are being actively tapered off opiate pain regimens without medical reason.

3.  When asked why the doctors were tapering for no reason patients reported they were told it was due to the CDC and DEA.  (“I cannot lose my license over this, you will need to deal with your pain”)

4.  Fifty percent of the ten million with legitimate long term, incurable painful diseases are completely taken off medicines that should never have been taken away lacking a medical reason.

5.  Two thirds of primary care doctors have quit prescribing opiate pain medicine in the last three years

6.  Picking up the slack, pain specialists now bursting at the seams to help those denied access for their disease, are being raided by federal and state drug squads for “having too many patients”, and “prescribing more than any other doctor” – a crime I never heard of.  Punished for helping out.

7.  This data to follow is informal and should have been obtained by the CDC.  But, the obvious is not always an illusion>  Reading the stories of 28,000 pain patients makes me believe these these probes are more than likely portray the truth.

These statistics are from those patients who have been tapered down or off their pain medicines:

–After tapering 89% had more pain, 11% less pain or no change 302 12-27

–Sleep was worse in 92%  (sleep deprivation is a new secondary disease from tapering)

–70% were forced to taper against their will with their strong protestations and tears ignored

–Dependence or having withdrawl is pretty much the same as addiction. 18% yes 2-4 82% no

— 2/3 of patients require more than 90mg Mme per day (CDC never checked if 90mg would work)

      (FDA, the rulemaking agency for opiates has not recommended tapering and by law and regulations  has no maximum amount or dose)

–Those doing “fine” after the tapering  15%

–negative impact on parenting – 78%

–negative impact on sexuality – 88%  (78% stopped having sex altogether)

–negative impact on  social activities like PTA, church, civic activities:  57% stopped activities,  major reduction 36%, no change 3%

– -“big” problems with relationships – 92%

— weight gain 45%, weight loss 35%, no change 20%

–considered an addict for taking pain medicine- 50% said yes

–Flagged in computers as “drug seekers” – 43%

— agree or disagree with the statement made by opiate opposed doctors that long term opiate medicine is ineffective:  82% disagree

–Percentage of painful disease patients refused medication because they did not have cancer -69%

–Statement by CDC Director Thomas Frieden MD that “doctors are the cause of the opioid epidemic” – 82% disagreed

–Veterans: after two months off meds or tapered are you better for it? Yes better 13% worse 29% a lot worse 58% 112 1-17

–Antidepressant helped: quite a bit 9% maybe helped some 22% did not help 69%

Side effects of antidepressant: major 53% mild to moderatle 26% none 26%

–Do you know a vet: 12% no tapering 51% Stopped, 37% reduced 141 1-14

–Percentage receiving “adequate pain medicines”  17%

– suicide numbers – unknown.  CDC is reporting sharp rise in suicides especially in women.  About 70% of the population of chronic painful diseases are women, reflecting similar weighting in autoimmune disease.  CDC has not reported and data on why the increase in suicides.  It must be assumed to be related to pain so great as to make life  not a life until proved otherwise. One CDC person interviewed indicated the notion of medication tapering suicides said they were not studying this.  Google “medium suicides” for case reports.

–Problems filling their doctors’ prescriptions at the pharmacy -33%

–Major “life changes” – 68%

–Tapered off or down on pain medicines  but still doing “ok”    6%  94% worse

— Forced tapering without a say so-  76%

— tapering effects on employment- no change 3%, negative effect 36%, had to quit job 61%

–once tapering was found to increase pain and decrease functioning how many had their original doses restored- – 13%, 76% of practitioners refused to restore  to previous effective levels

— Percentage of “doctor shoppers” who are addicts – 40%, percentage who are pain patients -60%

— Percentage of patients currently looking for doctors but cannot find one— 65% (of ten million presumably)

CDC recommends using alternative, second line treatments first, not a standard medical practice I am familiar with..  Generally we physicians like to treat with the most effective first, back ups if the drug of choice fails.  As a result of the stampede to more expensive, higher risk and reduced effectiveness we asked several questions in each poll–

–Back surgery, was it “worth it”? – yes 23% , 77% no

–Neck surgery, was it worth it?  – 68% no, 32% yes

–Physical Therapy helped – 10%,  PT made it worse 43%

— Alternate medicines worked as well as the opiates:  5%  yes, 95% no

–Lyrica – effective in only 8%, noticeable side effects 72%

–Neurontin, side effects in more than half, worked in only 13% little or none 35% side effects bad 46% side effects minimal 6%

–Spinal Stimulators implanted by surgery, “was it worth it”? – no in 86% (40-50K dollars)

–ketamine infusions – effective in 50%  

–Morphine pumps “did it relieve pain”? – 50% yes, 50% no (30-50K dollars plus monthly fees, surgical risks)

–Injection treatments, “would you recommend to others with the same diseases?”  47% said no (high risk of addisonian adrenal suppression and adhesive arachnoiditis, a disastrous lifelong disease)

–Radiofrequency ablation, “was it worth doing?” – 79% said no, 21% said yes  (extremely painful and expensive procedure)

–of those without addiction how many felt euphoria when starting: 16%, euphoria later

–euphoria from gabepentin: heard of this? 24% yes 296 1-2

Most patients are referred to pain clinics.  The status of licensing requirements is unknown. People who no longer are treated for their pain by their regular doctors, traditionally the ones who treated pain prior to 2015, who now go to “Pain Clinics” are asked to respond on twitter polls.

Contracts, pill counts, urine-analyses were traditionally reserved for opiate addicts.  It is not clear why these methods are forced on the pain patients abandoned by their primary care practitioners.  They report the following:

–forced to sign addiction style pain contracts -80%  restricting what pharmacies to go to,  forced birth control, etc  one person committed suicide after an ER relief prescription was refused by the pharmacy due to restrictive pain control (google Medium Suicides)

–numbers reporting good care at the pain clinic- -25%, not so good in 25%, “terrible” care 50%

–Number of pain clinics not prescribing actual pain medication – 25-31%

–Number of pain clinics offering “injections only” – 41%

–Number of pain clinics refusing to prescribe pain medicines until patient agrees to injections first–34%

–Number of pain clinics prescribing pain medicine according to FDA guidelines- 18%

–Number of patients that were not sent to Pain clinics by their primary care and followed in the office for the pain treatment – 19%, with 63% were “referred out”

–50% have to pay $100-$300 for each pain clinic visit after insurance pays

–Forced to have addiction type urine tests  in spite of no one ever reported to addict already on pain medications with false positive and negative rates leading to discharge from pain clinic and labeling as drug seekers on EHR records damming the patient for ever in receiving pain medication for any reason.

–How many have problems getting your pain meds at pharmacies: at chain pharmcies 55% at independent 1% 115 sample of 15k 12-16-17

— repeating the poll in a different way: now many in general have had problems filling your prescriptions at pharmacies- 33% have had a problem 31% at chains 2% at independent pharmacies 225 sample from 15k 12-17-17

— “honestly now, pulling no punches do you believe over prescribing by doctors is contributing to overdose deaths Yes 18% No 82% 284 votes of 15k 12-22-17

–the CDC and PROP Believes long term medication continues to be taken after three months just to hold off withdrawal Agree 18% Disagree 82% 273 votes of 15k 12-20-17

–of you looking for new doctors to prescribe pain meds how many docs/np’s/pa’s have you contacted 1-10 34% more than 10: 9% eventually successful 15% still looking 42% 122 votes

–are you getting proper and adequate treatment for your painful disease? yes getting good treatment 21% No not getting adequate treatment for your painful disease 79% 175 votes 12-23-17

–Reactions by doctors and practitioners when telling you are going to be tapered against your will: neutral 41% vindictive 29% nice or sad 24% gleeful 6% 228 1-22

–How many of you have been denied pain medicine because you don’t have cancer 69% 251 votes

–Medical society with plan for board protection 23 votes 17% yes

In general painful disease patients are also reporting:

–34% take both benzodiazepines and opiate with no problems reported in  87%, problems in 13%

–Two percent report benzodiazepines work best to relieve pain, opiates work best 52% and the combination of benzodiazepines and opiates work best in 36%, with neither working in  10%

–Outcomes with opiate pain medicine:  89% reporting “good”

–Numbers of patients in the universe of twitter followers officially disabled from their painful diseases: 53%

–requiring more than 90mg MME for pain control: 63%

These twitter polls were conducted by JATH over the last two years.  Many of the polls were validated by other polls outside of JATH.  The polls cannot be dismissed by saying they were not properly done.  The obvious is not always an illusion.  Are these randomly stratified samplings – no.    This information is provided to issue an alert.

Opiate drugs have an addiction rate of 0.5% – a major side effect but which can be managed easily if caught early.  If each prescriber would merely ask their patients if they have ever had an opiate we would stop new deaths from opiate addiction.   With this simple question no more teenagers will die due to ignorance of the pathophysiology of opiate addiction and the different types.  There is no such thing as “addiction” or “drug abuse”, but there are types of addiction  which are very different and need to be treated differently just as we do with the two types of diabetes.  

If the answer to the critical question “ever had a pain killer before” is YES the person will never opiate addict.  If the answer is NO they will have < 1% change for genetically determined opiate addiction.  The prescriber needs to warn “no” patients to report back if they have other than a sedative effect from the narcotic especially if they “go on a magic carpet ride”   If they do,  they have opiate addiction disease, type 2.   They need not seek out heroin and die.  No new cases of addiction need to die.  Ninety percent of opiate addiction occurs in teenage years.  Why? – First exposure.   Opiate addiction differs from other forms of addiction as it is triggered by the hidden propensity for immediate addiction.  This is why the news stories report the addiction from the doctors prescription – first exposure, not “substance exposure”.  

Thus identified, the patients can be medically treated in the office. Opiate addiction is serious side effect, but it is not fatal like many serious side effects of other prescription drugs.  We need to ask more about the facts of the two types of addiction and why they are different.  We cannot apply one solution for both.  This is where the mistakes have been made, and money wasted for 100 years.   We need medical facts, pathophysiological facts before we subject millions of people to the withdrawal of medical treatment without rhyme or reason.   It is their choice to take the risks or not take the risks, not the government, not doctors cowed into harming their patients, not the drug police.

Of any new idea,  Einstein said that some things are easy to understand but hard to believe.  This is offered in that light.  I have seen it.  Heads are in the sand. A nationwide tragedy  is really happening on a scale no one could ever imagine.  

Thomas F. Kline MD, Ph.D

Chronic and Rare Disease Specialist

Raleigh, North Carolina

Web: thomasklinemd.com

Email: thomasklinemd@gmail.com    Intelligent discussions are welcome

**JATH Educational Consortium LLC is a Raleigh based research group providing unrestricted data to the medical community and the general public for policy making and improvement of medical care